PAP-2a activators are compounds that specifically interact with and modulate the activity of the phosphatidic acid phosphatase type 2a enzyme, often abbreviated as PAP-2a. This enzyme is a member of a larger family of phosphatidic acid phosphatases, which are crucial in the regulation of lipid metabolism and signal transduction pathways. PAP-2a plays a significant role in the dephosphorylation of phosphatidic acid (PA) to diacylglycerol (DAG), and this reaction is fundamental in the synthesis of glycerolipids and in the control of the levels of PA, a lipid signaling molecule. Given that PA and DAG are both pivotal intermediaries in the synthesis of complex lipids and also serve as secondary messengers in various signaling cascades, the modulation of PAP-2a activity by these activators can have profound effects on cellular lipid composition and signaling.
The chemical class of PAP-2a activators encompasses a variety of molecular structures, each designed to bind to the enzyme and enhance its phosphatase activity. This binding can occur at the active site where the substrate interacts or at allosteric sites, which are distinct from the active site but still influence enzyme function. The interaction between PAP-2a activators and the enzyme is highly specific, often involving a series of molecular interactions that can include hydrogen bonding, hydrophobic effects, and van der Waals forces.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Adenylyl cyclase activator, raises intracellular cAMP levels, which can enhance the protein kinase A (PKA) pathway and may thereby upregulate PAP-2a. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist, can increase cAMP in cells, potentially affecting pathways that regulate PAP-2a. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-selective phosphodiesterase inhibitor, prevents cAMP degradation, possibly influencing pathways that PAP-2a is part of. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selective phosphodiesterase 4 inhibitor, increases cAMP, which can modulate signaling pathways associated with PAP-2a. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
PPAR-gamma agonist, involved in the regulation of inflammation and cell proliferation, pathways potentially connected with PAP-2a. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
cAMP analog, can activate PKA and hence might have an impact on pathways that regulate PAP-2a expression or activity. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
Bacterial endotoxin, known to elicit a strong immune response, which can alter cellular pathways relevant to PAP-2a. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Protein synthesis inhibitor, also known to activate stress-activated protein kinases, which could indirectly affect PAP-2a. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Active compound in turmeric, modulates numerous signaling molecules, possibly intersecting with PAP-2a-involved pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, although an inhibitor, its downstream effects can result in altered expression of proteins including those in pathways involving PAP-2a. |